{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:07:50Z","timestamp":1788199670940,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Fund of Yunnan Provincial Department of Education","award":["2024J0866"],"award-info":[{"award-number":["2024J0866"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03375-9","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:57:42Z","timestamp":1762153062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined effect of chronic inflammation and insulin resistance on stroke: a cohort study and mediation analysis"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0271-7571","authenticated-orcid":false,"given":"Yu","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1893-7239","authenticated-orcid":false,"given":"Zhiping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8079-1635","authenticated-orcid":false,"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"3375_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41582-023-00921-z","volume":"20","author":"ML Prust","year":"2024","unstructured":"Prust ML, Forman R, Ovbiagele B. Addressing disparities in the global epidemiology of stroke. Nat Rev Neurol. 2024;20:207\u201321.","journal-title":"Nat Rev Neurol"},{"key":"3375_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"VL Feigin","year":"2021","unstructured":"Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol"},{"key":"3375_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/17474930241308142","volume":"20","author":"VL Feigin","year":"2025","unstructured":"Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, et al. World Stroke Organization: global stroke fact sheet 2025. Int J Stroke. 2025;20:132\u201344.","journal-title":"Int J Stroke"},{"key":"3375_CR4","doi-asserted-by":"crossref","unstructured":"Tu W-J, Wang L-D, on behalf of the Special Writing Group of China Stroke Surveillance Report, Yan F, Peng B, Hua Y, et al. China stroke surveillance report 2021. Mil Med Res. 2023;10:33.","DOI":"10.1186\/s40779-023-00463-x"},{"key":"3375_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.1455","volume":"6","author":"W-J Tu","year":"2023","unstructured":"Tu W-J, Zhao Z, Yin P, Cao L, Zeng J, Chen H, et al. Estimated burden of stroke in China in 2020. JAMA Netw Open. 2023;6:e231455.","journal-title":"JAMA Netw Open"},{"key":"3375_CR6","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1161\/STROKEAHA.124.047820","volume":"55","author":"JJ McCabe","year":"2024","unstructured":"McCabe JJ, Walsh C, Gorey S, Arnold M, DeMarchis GM, Harris K, et al. Interleukin-6, C-reactive protein, and recurrence after stroke: a time-course analysis of individual-participant data. Stroke. 2024;55:2825\u201334.","journal-title":"Stroke"},{"key":"3375_CR7","doi-asserted-by":"crossref","unstructured":"Na S, Kim T, Koo J, Hong YJ, Kim S-H. Vessel wall enhancement and high-sensitivity CRP as prognostic markers in intracranial atherosclerotic stroke: A prospective cohort study. Eur Stroke J. 2025;23969873251317341.","DOI":"10.21203\/rs.3.rs-4684389\/v1"},{"key":"3375_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104054","volume":"80","author":"H-Q Gu","year":"2022","unstructured":"Gu H-Q, Yang K-X, Lin J-X, Jing J, Zhao X-Q, Wang Y-L, et al. Association between high-sensitivity C-reactive protein, functional disability, and stroke recurrence in patients with acute ischaemic stroke: a mediation analysis. EBioMedicine. 2022;80:104054.","journal-title":"EBioMedicine"},{"key":"3375_CR9","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3389\/fimmu.2020.01403","volume":"11","author":"M Mengozzi","year":"2020","unstructured":"Mengozzi M, Kirkham FA, Girdwood EER, Bunting E, Drazich E, Timeyin J, et al. C-reactive protein predicts further ischemic events in patients with transient ischemic attack or lacunar stroke. Front Immunol. 2020;11:1403.","journal-title":"Front Immunol"},{"key":"3375_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","volume":"582","author":"C de Luca","year":"2008","unstructured":"de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582:97\u2013105.","journal-title":"FEBS Lett"},{"issue":"Suppl 1","key":"3375_CR11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00592-005-0175-1","volume":"42","author":"AM Sharma","year":"2005","unstructured":"Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance. Acta Diabetol. 2005;42(Suppl 1):S3-8.","journal-title":"Acta Diabetol"},{"key":"3375_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.numecd.2005.06.010","volume":"15","author":"S Frontoni","year":"2005","unstructured":"Frontoni S, Bracaglia D, Gigli F. Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes. Nutr Metab Cardiovasc Dis. 2005;15:441\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3375_CR13","doi-asserted-by":"publisher","first-page":"304S","DOI":"10.1016\/S0895-7061(01)02236-1","volume":"14","author":"M Esler","year":"2001","unstructured":"Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens. 2001;14:304S-309S.","journal-title":"Am J Hypertens"},{"key":"3375_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2337\/diacare.14.3.173","volume":"14","author":"RA DeFronzo","year":"1991","unstructured":"DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173\u201394.","journal-title":"Diabetes Care"},{"key":"3375_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12933-023-02073-2","volume":"22","author":"X Tian","year":"2023","unstructured":"Tian X, Chen S, Xu Q, Xia X, Zhang Y, Wang P, et al. Magnitude and time course of insulin resistance accumulation with the risk of cardiovascular disease: an 11-years cohort study. Cardiovasc Diabetol. 2023;22:339.","journal-title":"Cardiovasc Diabetol"},{"key":"3375_CR16","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793\u2013801.","journal-title":"J Clin Invest"},{"key":"3375_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219\u201346.","journal-title":"Annu Rev Physiol"},{"key":"3375_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","volume":"15","author":"CK Glass","year":"2012","unstructured":"Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635\u201345.","journal-title":"Cell Metab"},{"key":"3375_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/STROKEAHA.122.039542","volume":"54","author":"A Jin","year":"2023","unstructured":"Jin A, Wang S, Li J, Wang M, Lin J, Li H, et al. Mediation of systemic inflammation on insulin resistance and prognosis of nondiabetic patients with ischemic stroke. Stroke. 2023;54:759\u201369.","journal-title":"Stroke"},{"key":"3375_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43:61\u20138.","journal-title":"Int J Epidemiol"},{"key":"3375_CR21","first-page":"439","volume":"29","author":"SS Bassuk","year":"2004","unstructured":"Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29:439\u201393.","journal-title":"Curr Probl Cardiol"},{"key":"3375_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.7326\/0003-4819-136-7-200204020-00014","volume":"136","author":"W Koenig","year":"2002","unstructured":"Koenig W, Pepys MB. C-reactive protein risk prediction: low specificity, high sensitivity. Ann Intern Med. 2002;136:550\u20132.","journal-title":"Ann Intern Med"},{"key":"3375_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-17-0883","volume":"178","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178:533\u201344.","journal-title":"Eur J Endocrinol"},{"key":"3375_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1747493021995595","volume":"17","author":"S Coveney","year":"2022","unstructured":"Coveney S, Murphy S, Belton O, Cassidy T, Crowe M, Dolan E, et al. Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic attack. Int J Stroke. 2022;17:163\u201371.","journal-title":"Int J Stroke"},{"key":"3375_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/STROKEAHA.122.040529","volume":"54","author":"JJ McCabe","year":"2023","unstructured":"McCabe JJ, Walsh C, Gorey S, Harris K, Hervella P, Iglesias-Rey R, et al. C-reactive protein, interleukin-6, and vascular recurrence after stroke: an individual participant data meta-analysis. Stroke. 2023;54:1289\u201399.","journal-title":"Stroke"},{"key":"3375_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.08.018","volume":"134","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhu L, Zhang B, Gao J, Zhao T, Fang S. Higher levels of C-reactive protein in the acute phase of stroke indicate an increased risk for post-stroke depression: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;134:104309.","journal-title":"Neurosci Biobehav Rev"},{"key":"3375_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2016.11.019","volume":"372","author":"A Itrat","year":"2017","unstructured":"Itrat A, Griffith SD, Alam S, Thompson N, Katzan IL. The role of very high high-sensitivity C-reactive protein levels on mortality after stroke. J Neurol Sci. 2017;372:1\u20135.","journal-title":"J Neurol Sci"},{"key":"3375_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002073","volume":"4","author":"MC Jim\u00e9nez","year":"2015","unstructured":"Jim\u00e9nez MC, Rexrode KM, Glynn RJ, Ridker PM, Gaziano JM, Sesso HD. Association between high-sensitivity C-reactive protein and total stroke by hypertensive status among men. J Am Heart Assoc. 2015;4:e002073.","journal-title":"J Am Heart Assoc"},{"key":"3375_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13167-024-00388-y","volume":"15","author":"T Wang","year":"2024","unstructured":"Wang T, Yi Z, Tan Y, Huang Y, Li T, Gao S, et al. Changes in the metabolic score for insulin resistance index for risk prediction of stroke in middle-aged and older Chinese population. EPMA J. 2024;15:599\u2013610.","journal-title":"EPMA J"},{"key":"3375_CR30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.numecd.2023.04.001","volume":"33","author":"G Feng","year":"2023","unstructured":"Feng G, Yang M, Xu L, Liu Y, Yu J, Zang Y, et al. Combined effects of high sensitivity C-reactive protein and triglyceride-glucose index on risk of cardiovascular disease among middle-aged and older Chinese: evidence from the China health and retirement longitudinal study. Nutr Metab Cardiovasc Dis. 2023;33:1245\u201353.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3375_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Liu L, Qi Y, Han N, Xu H, Wang Z, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2024;23:156.","journal-title":"Cardiovasc Diabetol"},{"key":"3375_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-025-02686-9","volume":"24","author":"G Huo","year":"2025","unstructured":"Huo G, Tang Y, Liu Z, Cao J, Yao Z, Zhou D. Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24:142.","journal-title":"Cardiovasc Diabetol"},{"key":"3375_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.diabres.2006.04.014","volume":"74","author":"K Matsumoto","year":"2006","unstructured":"Matsumoto K, Fujita N, Ozaki M, Tominaga T, Ueki Y, Miyake S. Coexistence of insulin resistance and inflammation effectively predicts cardiac disease but not stroke in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2006;74:316\u201321.","journal-title":"Diabetes Res Clin Pract"},{"key":"3375_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87\u201391.","journal-title":"Science"},{"key":"3375_CR35","doi-asserted-by":"publisher","first-page":"26055","DOI":"10.1016\/S0021-9258(19)74276-8","volume":"268","author":"R Feinstein","year":"1993","unstructured":"Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem. 1993;268:26055\u20138.","journal-title":"J Biol Chem"},{"key":"3375_CR36","first-page":"847","volume":"83","author":"SK Fried","year":"1998","unstructured":"Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"3375_CR37","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1074\/jbc.275.12.9047","volume":"275","author":"V Aguirre","year":"2000","unstructured":"Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem. 2000;275:9047\u201354.","journal-title":"J Biol Chem"},{"key":"3375_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature01137","volume":"420","author":"J Hirosumi","year":"2002","unstructured":"Hirosumi J, Tuncman G, Chang L, G\u00f6rg\u00fcn CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333\u20136.","journal-title":"Nature"},{"issue":"Suppl 1","key":"3375_CR39","doi-asserted-by":"publisher","first-page":"S307","DOI":"10.1016\/j.dsx.2017.03.006","volume":"11","author":"H Zand","year":"2017","unstructured":"Zand H, Morshedzadeh N, Naghashian F. Signaling pathways linking inflammation to insulin resistance. Diabetes Metab Syndr. 2017;11(Suppl 1):S307\u20139.","journal-title":"Diabetes Metab Syndr"},{"key":"3375_CR40","doi-asserted-by":"crossref","unstructured":"Bensussen A, Torres-Magallanes JA, Roces de \u00c1lvarez-Buylla E. Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue. Front Immunol. 2023;14:1014778.","DOI":"10.3389\/fimmu.2023.1014778"},{"key":"3375_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"S-H Lee","year":"2022","unstructured":"Lee S-H, Park S-Y, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46:15\u201337.","journal-title":"Diabetes Metab J"},{"key":"3375_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120129","volume":"287","author":"SY Park","year":"2021","unstructured":"Park SY, Lee HJ, Song J-H, Shin YK, Abd El-Aty AM, Ramadan A, et al. Dimethyl itaconate attenuates palmitate-induced insulin resistance in skeletal muscle cells through the AMPK\/FGF21\/PPAR\u03b4-mediated suppression of inflammation. Life Sci. 2021;287:120129.","journal-title":"Life Sci"},{"key":"3375_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110691","volume":"200","author":"S Suren Garg","year":"2023","unstructured":"Suren Garg S, Kushwaha K, Dubey R, Gupta J. Association between obesity, inflammation and insulin resistance: insights into signaling pathways and therapeutic interventions. Diabetes Res Clin Pract. 2023;200:110691.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03375-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:57:58Z","timestamp":1762153078000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3375"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03375-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants in our study were from the China Health and Retirement Longitudinal Study (CHARLS). CHARLS informed consent was obtained from each participant before conducting the investigation.\u00a0The CHARLS study was approved by the Biomedical Ethics Committee of Peking University (approval number: IRB00001052-11015). All research methods were conducted in accordance with the requirements of the Declaration of Helsinki and relevant legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1056"}}